TransMontaigne Partners L.P.
We are investigating TransMontaigne Partners L.P. (“TransMontaigne”) (NYSE: TLP) regarding the sale of TransMontaigne to TLP Finance Holdings, LLC for $41.00 per share.
We are investigating TransMontaigne Partners L.P. (“TransMontaigne”) (NYSE: TLP) regarding the sale of TransMontaigne to TLP Finance Holdings, LLC for $41.00 per share.
We are investigating Tribune Media Company (“Tribune Media”) (NYSE: TRCO) regarding the sale of Tribune Media to Nexstar Media Group, Inc. for $46.50 per share.
We are investigating SI Financial Group, Inc. (“SI Financial”) (NasdaqGM: SIFI) regarding the sale of SI Financial to Berkshire Hills for 0.2141 shares of Berkshire Hills for each share of SI Financial stock owned.
We are investigating Nutrisystem, Inc. (“Nutrisytem”) (NasdaqGS: NTRI) regarding the sale of Nutrisystem, to Tivity Health, Inc. (“Tivity”) for $38.75 in cash and 0.2141 Tivity shares for each share of Nutrisystem owned.
We are investigating the Board of Directors of Trinity Capital Corporation (“Trinity” or the “Company”) (OTC: TRIN) for possible breaches of fiduciary duty related to the sale of the company to Enterprise Financial Services, Inc. (“ Enterprise”). Under the terms of the proposed transaction, Trinity shareholders are only anticipated to receive $1.84 in cash and … Read more
We are investigating the Board of Directors of Avenue Therapeutics, Inc. (“Avenue” or the “Company”) (NasdaqCM: ATXI) for possible breaches of fiduciary duty related to the sale of the company to InvaGen Pharmaceuticals, Inc. and Madison Pharmaceuticals, Inc. Under the terms of the proposed transaction, Avenue shareholders are only anticipated to receive $13.92 for each … Read more
We are investigating the Board of Directors of Dominion Energy Midstream Partners, LP (“Dominion Energy Midstream” or the “Company”) (NYSE: DM) for possible breaches of fiduciary duty related to the sale of the company to Dominion Energy, Inc. Under the terms of the proposed transaction, Dominion Energy Midstream shareholders are only anticipated to receive 0.2492 … Read more
We are investigating the Board of Directors of Pacific Biosciences of California, Inc. (“PACB” or the “Company”) (NasdaqGS: PACB) for possible breaches of fiduciary duty related to the sale of the company to Illumnia, Inc. Under the terms of the proposed transaction, PACB shareholders are only anticipated to receive $8.00 in cash for each share … Read more
We are investigating the Board of Directors of WildHorse Resource Development Corporation (“WildHorse” or the “Company”) (NYSE: WRD) for possible breaches of fiduciary duty related to the sale of the company to Chesapeake Energy Corporation (“Chesapeake”). Under the terms of the proposed transaction, WildHorse shareholders are only anticipated to receive 5.989 shares of Chesapeake common … Read more
We are investigating the Board of Directors and Officers of TESARO, Inc. (“Tesaro” or the “Company”) (NasdaqGS: TSRO) for possible breaches of fiduciary duty.